This recent study by Bar-Zion et al. in the prominent journal, Cancer Research, highlights the significance and validity of contrast-enhanced ultrasound and photoacoustics (PA) to assess vascularity in tumors and to monitor efficacy of treatment dynamically over time.
Join host Dr. Alexadra Eichten of Regeneron Phramaceuticals on this webinar as she discusses utilizing non-invasive imaging modalities to assess effects of VEGF blockade in tumors.
Join Minalini Lakshman as she discusses Preclinical evaluation of lead candidates, tackling translational challenges and next generation cancer therapy.
This webinar is presented by Andrew Needles, Senior Manager, Product Innovation, FUJIFILM, VisualSonics, Inc. This webinar explores the capabilities of the Vevo 3100 Ultrasound Imaging System for preclinical research across cardiovascular, cancer, developmental, abdominal and neurobiology
This webinar is Part 2 of the Webinar hosted by Dr. Walker III. Dr. Walker continues the discussion on a novel 3-dimensional micro-ultrasound approach to automated measurement of carotid arterial plaque volume as a biomarker for experimental atherosclerosis.
Take a look at the NEW Vevo LAZR-X Photoacoustic Imaging System (featured at WMIC - World Molecular Imaging Congress in September). Presented by Drew Heinmiller, Product Manager, Fujifilm VisualSonics.
Preclinical in vivo studies is a critical step in drug development. In vivo imaging in such studies can benefit drug development with rapid and predictive assays to assess drug toxicity and efficacy to reduce clinical attrition rates. High frequency ultrasound imaging will be addressed in this regard by the panel of speakers.
Presented by Andrew Heinmiller, Product Manager - Photoacoustics, FUJIFILM VisualSonics Inc. In this webinar, learn about visualizing and quantifying molecular markers with photoacoustics.
In this webinar, Dr. Srivallesha Mallidi will discuss the breadth of drug discovery research from designing cancer therapeutics to testing its efficacy for clinical utility. Specifically, she will share her success with ultrasound guided photoacoustic imaging to address this breadth in drug discovery research.
The unique feature of obtaining tumor structure and functional properties using the Vevo LAZR system enabled us to monitor therapies such as photodynamic therapy and predict tumor recurrence. By precisely monitoring the change in oxygen saturation within the 3D tumor volume, we could predict regions that did not have sufficient therapeutic effect and hence recurred at later time point. Read more.
Join Dr. Hon Leong and Matthew Lowerison from Western University for this exciting webinar on evaluating anti-angiogenic treatment effect on CAM RCC xenograft tumors to detect patient-specific drug resistance(s)
Personalized medicine is beginning to appear more and more in discussions on the future of health care.This was exactly the over-arching topic of a recent live webinar we hosted. Read more.
Learn about photoacoustic technology and how it was used in a Case Study to assess targeted vs nonspecific uptake of nanoparticles in tumors in vivo. The results are incredible!
